| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.096 | 0.05 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.072 | 0.1 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | -0.068 | 0.1 |
| mRNA | PHA-665752 | CCLE | pan-cancer | AAC | -0.064 | 0.2 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.043 | 0.3 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.045 | 0.4 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.04 | 0.4 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | -0.037 | 0.4 |
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | -0.036 | 0.4 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | -0.03 | 0.6 |